At Midi, we strongly believe women should have access to treatments that can help address midlife symptoms, including weight gain
Facilities should have emergency protocols and equipment available to handle potential complications
IGF-1 LR3 IGF-1 LR3 is a modified form of insulin-like growth factor-1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension, designed to have reduced binding to IGF-binding proteins, which increases its free, biologically active fraction and potency
Dosage and ingredients vary from person to person
Tsai WH, Sung FC, Chiu LT, Shih YH, Tsai MC, Wu SI
Highlights of prescribing information [Prescribing information]